Data de publicação: 23/03/2022 - 16:42
A study by researchers of Fiocruz and of the University of Columbia has identified promising results in a combination of antiviral drugs for the treatment of COVID-19. Scientists showed that there is a synergy between the substances, inhibiting the enzymes that allow Sars-CoV-2 to multiply more effectively. Together, the drugs may reduce viral replication about ten times more than if taken separately.
The drugs studied are already...
Notícias
Data de publicação: 08/04/2022 - 15:33
Last Tuesday (March 29), Fiocruz and Drugs for Neglected Diseases initiative (DNDi) signed a Memorandum of Understanding for dengue fever research and treatment. The occasion also sealed a Strategic Research Alliance between the two institutions and the joint submission of a project to the Finep Public Call for Neglected Diseases.
In addition to signing the Memorandum of Understanding for dengue fever, the occasion sealed a Strategic...
Notícias
Data de publicação: 16/03/2022 - 11:20
Through the Institute of Drug Technology (Farmanguinhos) and French laboratory Servier, Fiocruz signed, last Thursday (March 10th), a Memorandum of Understanding for technical cooperation to develop new drugs against chronic diseases, from a new pharmaceutical platform. This is an innovative technology based on the prolonged release of the active ingredient in the body, resulting in efficacy, safety, and more compliance and practicality for...
Notícias
Data de publicação: 14/03/2022 - 12:25
An article published in Nature Biomedical Engineering, last Monday (March 7th), reveals the potential use of synthetic biosensors in rapid, decentralized, and low-cost tests for the diagnosis of patients infects with the zika virus. The study was led by scientists of the University of Toronto (CA), who developed the sensors and the portable digital platform where samples are processed, and had the partnership of researchers from Fiocruz...
Notícias
Data de publicação: 11/03/2022 - 12:25
During a conference in London, attended by the world’s most prominent health authorities and specialists, Fiocruz president, Nísia Trindade Lima, emphasized the need to decentralize vaccine production and to strengthen investments in research and development, in order to reduce inequalities between countries. Her statement was made during the Global Summit for Preparation for Pandemics, last Tuesday (March 8th). Organized by the...
Notícias
Data de publicação: 15/03/2022 - 13:35
In reference to International Women’s Day, the Pasteur Institute, in Paris, paid homage to five female scientists that are part of the institution's international scientific cooperation network. Among them, representing the Americas, was researcher Teca Galvão, from the Laboratory for Functional Genomics and Bioinformatics of the Oswaldo Cruz Institute (IOC/Fiocruz).
The homage highlighted the specialist’s education,...
Notícias
Data de publicação: 21/03/2022 - 12:54
Diseases transmitted from animals to humans, such as spotted fever, Q fever, hantavirus diseases, and arenavirus diseases present early clinical symptoms that are similar to those of other infections, including fever, headache, or aches in the body, and malaise. Amidst an epidemic, when all eyes are focused on diseases that are circulating widely, such as dengue fever or Covid-19, these zoonoses are often forgotten when diagnosing a patient....
Notícias
Data de publicação: 25/03/2022 - 16:07
By means of the Immunobiological Technology Institute (Bio-Manguinhos), Fiocruz has been selected by the Ministry of Health to represent Brazil at the BRICS Center of Vaccine Research and Development. Launched this Tuesday (March 22) by the group of countries made up by Brazil, Russia, India, China and South Africa, the goal of the initiative is to share experiences, information and training, so as to strengthen the productive capacity of the...
Notícias
Data de publicação: 30/03/2022 - 10:15
In a meeting promoted on March 28, by the Center for International Relations in Health (Cris/Fiocruz) and the Vice-Presidencies of Research and Biological Collections (VPPCB) and Education, Information and Communication (VPEIC), members of the Consulate General of the United States in Rio de Janeiro continued the partnership process initiated in 2021. The aim is to expand scientific cooperation between Fiocruz and American institutions....
Notícias
Data de publicação: 14/03/2022 - 11:43
March is celebrated as the month of International Women’s Day, but it is also the time to debate gender inequalities and guarantee of rights. This issue was highlighted by the ambassador of UN Women for Latin America, María del Carmen Squeff, at the Advanced Seminar in Global Health and Health Diplomacy of the Fiocruz Global Health Center (CRIS/Fiocruz), last Wednesday (March 9th). At the event, which was attended by researchers in...
Notícias
Data de publicação: 03/03/2022 - 13:20
Countries with high vaccination coverage are adopting a dangerous rhetoric according to which the pandemic is over or almost over. But how can one state that when there are still 70,000 people dying of COVID-19 in a week, worldwide? The warning was issued by the Assistant Director-General for Access to Medicines and Pharmaceutical Products of the World Health Organization (WHO), Brazilian Mariângela Batista Galvão Simão. At...
Notícias
Data de publicação: 09/02/2022 - 17:07
A study analyzed the geographic distribution and the incidence of co-infection with a human T-lymphotropic virus (HTLV) and a human immunodeficiency virus (HIV) in Bahia, which is an endemic state for both retroviruses. The research was carried out using all samples submitted to serological tests at the Central Public Health Laboratory of Bahia (Lacen-BA), from 2004 to 2013. The total was about 130,000 samples from 358 of the 417 municipalities...
Notícias
Data de publicação: 15/02/2022 - 12:19
COVID-19 diagnostics, therapeutics, and vaccines are powerful reminders: health technologies can help to shape the way in which societies control disease. Challenges in ensuring global, equitable access to these fruits of biomedical research and development (R&D) during the COVID-19 pandemic have highlighted the urgency of reorienting the system towards the public interest. The first step is a clearer articulation of what R&D in the...
Notícias
Data de publicação: 14/12/2021 - 17:24
In a pioneering initiative, the Foundation inaugurates this Monday (13/12), COVID-19 Biobank (BC19-Fiocruz). Located in Rio de Janeiro, at Expansão campus, BC19-Fiocruz will enable the design and conduct of research, technological development and clinical trials related to COVID-19, regardless of the geographic location of human biological material and viruses. With the capacity to store up to one and a half million samples of human and...
Notícias
Data de publicação: 06/12/2021 - 14:57
The Oswaldo Cruz Foundation, by means of the Fio-Schisto, the Translational Research Program in Schistosomiasis, informs that researcher Otávio Pieri, of the Oswaldo Cruz Institute (IOC), was invited to become part of the World Health Organization (WHO) group on schistosomiasis and helminth diseases transmitted through the soil (geo helminth diseases). Fio-Schisto is bound to the Vice-Presidency of Biological Research and Collections....
Notícias
Data de publicação: 13/12/2021 - 17:59
Designated by the United Nations, December 12th is celebrated every year as International Universal Health Coverage Day. The theme this year is Leave no one’s health behind: Invest in Health Systems for All - an issue that gained even more significance as the COVID-19 pandemic rolled on. This year’s campaign will feature a video showing people from all over the world who have shown leadership and vision in this matter, the so-called...
Notícias
Data de publicação: 10/12/2021 - 12:09
For one week Fiocruz will be at Expo Dubai. Starting on December 28th, visitors will be able to learn a little more about the Foundation's work and even take a virtual tour of Campus Manguinhos at the Brazil Pavilion. The World Expo takes place every five years and brings themes such as technology and sustainability. It began on October 1st, surrounded by care so that visitors can have interactive participation, but without crowds.
The...
Notícias
Data de publicação: 21/10/2021 - 13:21
Este relatório apresenta resultados preliminares da pesquisa “Covid-19, risco, impacto e resposta de gênero”, desenvolvida no Brasil pela Fiocruz e instituições parceiras1. Diversos temas relacionados aos impactos da pandemia da Covid-19 na vida das mulheres são contemplados pela pesquisa, mas este relatório concentra-se no tema da insegurança alimentar. São apresentados relatos...
Documento/Arquivo
Data de publicação: 25/04/2017 - 15:22
The newsletter of the Center for International Relations in Health (Cris) is prepared by the Coordination of Social Communication for Fiocruz (CCS), an advisory board of the Presidency of Fiocruz with the support of the Institute of Scientific and Technological Communication and Information in Health (Icict/Fiocruz).
Editorial supervision: Elisa Andries (CCS) - elisa.andries@fiocruz.br
Edition: Cristina Azevedo (CCS) -...
Páginas Institucionais (antigas)
Data de publicação: 06/12/2021 - 13:46
The search for a coordinated solution to a common problem brought together representatives from Brazil, Argentina, Paraguay, Uruguay, and Bolivia this Tuesday (9/11) in the auditorium of the Immunobiological Technology Institute (Bio-Manguinhos). Organized by the Presidency Pro Tempore of Brazil in Mercosur, the Technical Seminar on Access to COVID-19 Vaccines: National Strategies and Possibilities of Expansion of the Regional Productive...
Notícias
Data de publicação: 17/12/2021 - 12:41
Continuing an institutional movement to promote science through the dissemination of actions, research, events and courses in other languages, Fiocruz has just incorporated two new courses to the Global Health Training Centre. This time they were "What is Open Science?" and "Open Access", which were translated from Portuguese into English and Spanish. They integrate the series on Open Science developed by the Fiocruz Virtual...
Notícias
Data de publicação: 16/12/2021 - 09:50
A project resulting from a partnership between the Ministry of Health, Fiocruz, Lacen-PR, and the Federal University of São Paulo (Unifesp) was one of those selected by the U.S. Centers for Disease Control and Prevention (CDC) for funding, as part of the creation of two global networks aimed at fighting antimicrobial resistance. With Ana Paula Assef, head of the Hospital Infection Research Laboratory (LAPIH) at the Oswaldo Cruz Institute...
Notícias
Data de publicação: 03/01/2022 - 13:05
A third AstraZeneca vaccine dose significantly increases neutralizing antibodies levels against the Ômicron variant (B.1.1.529), a new study indicates. The research was conducted independently by researchers from different institutions, including Fiocruz and Oxford University. And these results were published in preprint form on the bioRxiv platform (Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses) on...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
